Wenting Li

Ms. Wenting Li

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2022 in Environmental Science & Technology
Verified
Journal Article
Closed access
Carrie A McDonoughCarrie A McDonough
Carrie A McDonough
WLWenting Li
Wenting Li
HBHeather N. Bischel
Heather N. Bischel
ASAmila O. De Silva
Amila O. De Silva
JDJamie C. DeWitt
Jamie C. DeWitt

17 March 2021 in Toxics
Verified
Journal Article
Open access
PDF file
WLWenting Li
Wenting Li
YHYuhong Hu
Yuhong Hu
HBHeather Bischel
Heather Bischel
Drinking water contaminated by fluorosurfactant-based aqueous film-forming foams (AFFF) is a source of human exposure to poly- and perfluoroalkyl substances (PFAS). However, assessment of bioaccumulation potentials of diverse PFAS in commercial products such as AFFF have been insufficient and challenging, especially due to a lack of analytical standards. Here we explore the value of suspect screening, equilibrium dialysis, and molecular-docking simulations to identify potentially bioaccumulative PFAS. We exposed human serum albumin (HSA) protein to dilutions of a legacy AFFF produced by 3M in 1999 using equilibrium dialysis and screened in-vitro protein-binding affinities using high-resolution mass spectrometry (HRMS). Through suspect screening, we identified 32 PFAS and 18 hydrocarbon surfactants in the AFFF that bound to HSA. Quantification of noncovalent association constants for 26 PFAS standards confirmed that many PFAS, including the short-chain perfluoropropane sulfonic acid (log Ka= 4.1 ± 0.2 M−1), exhibit strong binding affinities with HSA. At least five PFAS in AFFF (including three PFAS with less than five perfluorocarbons) remained bound to the precipitated HSA pellet after extensive solvent washing—an indication of high PFAS binding potential. Three PFAS (PFBS, PFOS, and PFOA) were confirmed in the protein pellet with analytical standards and quantified after acid digestion—this sample fraction accounted for 5 to 20% of each compound mass in the sample. We calculated pseudo-bioconcentration factors (BCFpseudo) for PFAS that suspect screening flagged as noncovalently bound or potentially covalently bound. Most PFAS exhibiting high BCFpseudo, especially those with seven perfluorocarbons, contained a carboxylic acid or a sulfonic acid. Finally, we used molecular docking to simulate HSA binding affinities for 62 ligands (26 PFAS targets, 18 PFAS qualified in AFFF, and 18 hydrocarbon surfactants qualified in AFFF). We found that molecular docking can effectively separate HSA-binding and -nonbinding compounds in AFFF. In-vitro and in-silico approaches described in this study provide replicable, high-throughput workflows for assessing bioaccumulation potentials of diverse PFAS in commercial products.

9 April 2026 in Environmental Science & Technology Letters
Verified
Journal Article
Open access
WLWenting Li
Wenting Li
HBHeather Bischel
Heather Bischel
The structural diversity of poly- and perfluoroalkyl substances (PFASs) poses challenges for class-based chemical hazard assessments. Computational simulations of PFAS-protein binding provide a means to improve screening-level evaluations by considering molecular interactions with toxicologically relevant proteins. Many PFASs are known to interact with carrier and channel proteins that influence bioaccumulation and toxicity, yet experimental data remain limited. To address this gap, we developed multicondition quantitative structure–activity relationship (QSAR) models that incorporate PFAS-protein associations. We simulated interactions of 4,397 PFASs with six health-relevant proteins, generating molecular docking binding scores for 12 ligand-binding sites. We then constructed seven bioactivity prediction models, integrating 44 additional chemical descriptors for each target. Training used binary bioactivity classifications for 560 PFASs derived from public toxicology and bioactivity databases. Using the best performing model (random forest), we classified the bioactivity potential of 2,649 PFASs within the applicability domain. Strong binding of PFASs to human serum albumin (fatty acid binding sites 3 and 4) and peroxisome proliferator-activated receptor γ, along with molecular complexity and the number of saturated hetero rings, were associated with PFAS bioactivity. A structure–activity landscape index analysis further suggested that nonfluorinated moietiesincluding bromine substitution, benzimidazole, and dinitroaniline groupscontribute to PFAS bioactivity.